Clinical use of biomarkers in neurodegenerative disorders

The prevalence of neurodegenerative disorders is increasing dramatically and one of the major challenges today is the need of early and accurate diagnosis, the other is the need of more effective therapies -in turn the development of such therapies also requires early and accurate diagnosis-. The ma...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Kaituhi matua:	Manuel Menendez-Gonzalez
Hōputu:	Online
Reo:	Ingarihi
I whakaputaina:	Frontiers Media SA 2021
Ngā marau:	RC321-571 Q1-390 Neurodegenerative Diseases neurodegenerative disease Parkinson's disease MTAi biomarker Huntington's disease CSF biomarkers Frontotemporal dementia (FTD) thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Urunga tuihono:	17793
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!